CH
China Traditional Chinese Medicine Holdings Co. Limited
CHIZF · OTC
$0.16 +0.00% (+$0.00)
Market Cap ¥5.51B
P/E Ratio -
Div. Yield -
ROE 1.62%
Bulios Fair Price
$0.22
34.9% upside
Current Price
$0.16
Undervalued Fair Value Overvalued
According to Bulios Fair Price, CHIZF is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Moderate
4/9Valuation
100 /100
Cheap EV/EBITDA 2.83x
P/S 0.38x
P/B 0.27x
Growth
50 /100
Stable Rev. growth 0.14%
FCF growth 51.29%
Book val. growth 0.52%
Profitability
47 /100
Moderate Gross margin 48.09%
Net margin 2.32%
Op. margin 2.07%
Quality
6 /100
Poor ROIC 1.40%
ROE 1.62%
ROA 1.03%
Debt
88 /100
Low Debt/Equity 0.12x
Current ratio 2.29x
Int. coverage 3.08x
Stability
41 /100
Moderate Beta 0.73x
Rev. volatility 21.82%
EPS volatility 418.16%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about CHIZF
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Jun Yang
Employees
14,846
Headquarters
Hong Kong
Upcoming events
19 MAR
Earnings
Upcoming earnings report